Catalyst Wire Dossier Catalyst Wire Dossier

Fanhdi

· Grifols Therapeutics LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fanhdi, covering 2024-07-08 to 2024-07-08. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Fanhdi®, a High-purity Von Willebrand Containing FVIII Concentrate, in Pediatric Patients With Von Willebrand Disease [Phase 4]

See pricing